1. CIBMTR - Progress Report January – December 2014. JR Passweg, et al., HSCT in Europe 2014, Nature 2016. JR Passweg, et al. Bone Marrow Transplantation. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. 2015 (50);476-482.
  2. Hill JA, et al. Blood. Abstract: The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality. Feb 2016.
  3. Feghoul L. et, al. 2015 Clinical Microbiology Infection; Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment. 21:7:701-709.
  4. Gray GC, et al. Clinical Infectious Disease. Genotype Prevalence and Risk Factors for Severe Clinical Adenovirus Infection, United States 2004–2006. 2007;45:1120-1131
  5. Echavarrfa M. Clinical Microbiology Reviews; Adenoviruses in Immunocompromised Hosts. 2008 Oct. 21:4: 704-715
  6. Sawinski D, et al. Nephrology Dialysis Transplantation. BK virus infection: an update on diagnosis and treatment. Feb 2014.
  7. Hirsch H, et al. Clinical Infectious Diseases; BK Virus: Opportunity Makes a Pathogen. 2005 Aug. 41(3): 354-360.
  8. Leggiadro, RJ. Norovirus Gastroenteritis in Immunocompromised Patients Disclosures Pediatric Infectious Disease. 2013;32(4):388
  9. Luscalov, S. Clujul Medical. Cytomegalovirus infection in immunosuppressed patients after kidney transplantation. 2016. 89(3), 343–346.
  10. Belongia, E, et al. Clinical Medicine & Research; Smallpox Vaccine: The Good, the Bad, and the Ugly. 2003 Apr. 1(2): 87-92.
  11. National Health Services. Norovirus (website). October 2015.
  12. Centers for Disease Control and Prevention. Norovirus Worldwide (website). June 2016.
  13. Lopman, B et al. Centers for Disease Control and Prevention. Global Burden of Norovirus and Prospects for Vaccine Development. August 2015.
  14. Bartsch, S. M. PLoS ONE. Global Economic Burden of Norovirus Gastroenteritis. 2016. 11(4).
  15. Centers for Disease Control and Prevention. Prevent the Spread of Norovirus (website). November 2016.
  16. Bok, K, et al. New England Journal of Medicine. Norovirus Gastroenteritis in Immunocompromised Patients. 2013. 368(10): 971.
  17. Maschmeyer, G, Ljungman, P. Principles and Practice of cancer Infectious Diseases. Infections in hematopoietic stem cell transplant recipients. 2011. 17-25.
  18. Knowles WA. Advances in Experimental Medicine and Biology. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). 2006. 577:19-45.
  19. Hariharan S. Kidney Int. BK virus nephritis after renal transplantation. 2006 Feb. 69(4):655-62.
  20. Recommendations of the Center for International Blood and Marrow Transplant Research (CIBMTR®), the National Marrow Donor Program (NMDP), the European Blood and Marrow Transplant Group (EBMT), the American Society of Blood and Marrow Transplantation (ASBMT), the Canadian Blood and Marrow Transplant Group (CBMTG), the Infectious Disease Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the Association of Medical Microbiology and Infectious Diseases Canada (AMMI), and the Centers for Disease Control and Prevention (CDC), Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., …Boeckh, M. A. (2009). Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplant Recipients: A Global Perspective. Biology of Blood and Marrow